Kenneth Myszkowski - Jun 27, 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role: Chief Financial Officer
Signature: /s/Kenneth Myszkowski
Stock symbol: ARWR
Transactions as of: Jun 27, 2023
Transactions value $: -$543,000
Form type: 4
Date filed: 6/29/2023, 06:41 PM
Previous filing: Jan 5, 2023
Next filing: Jan 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARWR	Common Stock	Sale	-$543K	-15K	-3.78%	$36.20	382K	Jun 27, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $36.08 to $36.26, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
F2	Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.

Content

The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $36.08 to $36.26, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.

Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.